Jaro Ankerst

2.2k total citations
94 papers, 1.7k citations indexed

About

Jaro Ankerst is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Genetics. According to data from OpenAlex, Jaro Ankerst has authored 94 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pulmonary and Respiratory Medicine, 32 papers in Physiology and 21 papers in Genetics. Recurrent topics in Jaro Ankerst's work include Asthma and respiratory diseases (27 papers), Virus-based gene therapy research (19 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (19 papers). Jaro Ankerst is often cited by papers focused on Asthma and respiratory diseases (27 papers), Virus-based gene therapy research (19 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (19 papers). Jaro Ankerst collaborates with scholars based in Sweden, United Kingdom and United States. Jaro Ankerst's co-authors include Hans Sjögren, Anna Nopp, S. G. O. Johansson, H. Öman, Leif Bjermer, Mona Palmqvist, Ellen Tufvesson, Sune Svanberg, Katarina Svanberg and R. Fäldt and has published in prestigious journals such as Nature, The Journal of Experimental Medicine and JNCI Journal of the National Cancer Institute.

In The Last Decade

Jaro Ankerst

93 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jaro Ankerst Sweden 23 758 720 359 278 241 94 1.7k
Jacques Hébert Canada 26 794 1.0× 1.1k 1.6× 673 1.9× 539 1.9× 310 1.3× 84 2.7k
Harold H. Newball United States 23 921 1.2× 1.0k 1.4× 411 1.1× 873 3.1× 467 1.9× 54 2.6k
Jeffrey J. Atkinson United States 26 904 1.2× 277 0.4× 128 0.4× 406 1.5× 636 2.6× 48 2.3k
J J Mascali United States 14 190 0.3× 570 0.8× 198 0.6× 564 2.0× 253 1.0× 22 1.3k
Raphael Breuer Israel 31 1.9k 2.5× 409 0.6× 83 0.2× 360 1.3× 564 2.3× 113 3.1k
Musa Khaitov Russia 26 198 0.3× 618 0.9× 730 2.0× 557 2.0× 461 1.9× 143 2.2k
Jean LeRiche Canada 29 2.1k 2.8× 450 0.6× 114 0.3× 115 0.4× 594 2.5× 54 3.3k
John R. Shainoff United States 26 1.3k 1.7× 278 0.4× 112 0.3× 73 0.3× 330 1.4× 68 2.0k
Annemarie van Schadewijk Netherlands 28 1.1k 1.4× 790 1.1× 97 0.3× 717 2.6× 552 2.3× 52 2.6k
Shaul Kochwa United States 26 266 0.4× 422 0.6× 72 0.2× 271 1.0× 798 3.3× 54 2.4k

Countries citing papers authored by Jaro Ankerst

Since Specialization
Citations

This map shows the geographic impact of Jaro Ankerst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaro Ankerst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaro Ankerst more than expected).

Fields of papers citing papers by Jaro Ankerst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaro Ankerst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaro Ankerst. The network helps show where Jaro Ankerst may publish in the future.

Co-authorship network of co-authors of Jaro Ankerst

This figure shows the co-authorship network connecting the top 25 collaborators of Jaro Ankerst. A scholar is included among the top collaborators of Jaro Ankerst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaro Ankerst. Jaro Ankerst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Westergren‐Thorsson, Gunilla, Leif Bjermer, Jaro Ankerst, et al.. (2024). Expression of Stress-Induced Genes in Bronchoalveolar Lavage Cells and Lung Fibroblasts from Healthy and COPD Subjects. International Journal of Molecular Sciences. 25(12). 6600–6600. 2 indexed citations
3.
Frantz, Sophia, Julie Weidner, Jaro Ankerst, et al.. (2022). Single-nucleotide polymorphisms in the sulfatase-modifying factor 1 gene are associated with lung function and COPD. ERJ Open Research. 8(2). 668–2021. 4 indexed citations
4.
Diamant, Zuzana, Jaro Ankerst, Susanna Kumlien Georén, et al.. (2022). Neutrophil phenotypes in bronchial airways differentiate single from dual responding allergic asthmatics. Clinical & Experimental Allergy. 53(1). 65–77. 5 indexed citations
5.
Tufvesson, Ellen, Finn Radner, Ulf Nihlén, et al.. (2021). A new protocol for exercise testing in COPD; improved prediction algorithm for WMAX and validation of the endurance test in a placebo-controlled double bronchodilator study. Therapeutic Advances in Respiratory Disease. 15. 2663616782–2663616782. 1 indexed citations
6.
Tufvesson, Ellen, et al.. (2020). <p>Type 2 Inflammatory Biomarker Response After Exercise Challenge Testing</p>. Journal of Asthma and Allergy. Volume 13. 269–274. 7 indexed citations
7.
Tufvesson, Ellen, Finn Radner, Ulf Nihlén, et al.. (2020). <p>Reduced Variability of Endurance Time in New Protocols for Exercise Tests in COPD</p>. International Journal of COPD. Volume 15. 3003–3012. 1 indexed citations
8.
Ankerst, Jaro, et al.. (2015). Acinar ventilation heterogeneity in COPD relates to diffusion capacity, resistance and reactance. Respiratory Medicine. 110. 28–33. 13 indexed citations
9.
Erjefält, Jonas S., et al.. (2014). Oral iodinated activated charcoal improves lung function in patients with COPD. Respiratory Medicine. 108(6). 905–909. 1 indexed citations
10.
11.
Ankerst, Jaro, Anna Nopp, S. G. O. Johansson, Justus Adédoyin, & H. Öman. (2009). Xolair Is Effective in Allergics with a Low Serum IgE Level. International Archives of Allergy and Immunology. 152(1). 71–74. 15 indexed citations
12.
Tronde, Ann, Michael Gillen, Lars Borgström, Jan Lötvall, & Jaro Ankerst. (2008). Pharmacokinetics of Budesonide and Formoterol Administered Via 1 Pressurized Metered‐Dose Inhaler in Patients With Asthma and COPD. The Journal of Clinical Pharmacology. 48(11). 1300–1308. 20 indexed citations
13.
Nopp, Anna, S. G. O. Johansson, Jaro Ankerst, Mona Palmqvist, & H. Öman. (2007). CD‐sens and clinical changes during withdrawal of Xolair after 6 years of treatment. Allergy. 62(10). 1175–1181. 69 indexed citations
14.
Aronsson, David D., Ellen Tufvesson, Jaro Ankerst, & Leif Bjermer. (2007). Allergic rhinitis with hyper‐responsiveness differ from asthma in degree of peripheral obstruction during metacholine challenge test. Clinical Physiology and Functional Imaging. 28(2). 81–85. 22 indexed citations
15.
16.
Vilsvik, Jan, Jaro Ankerst, Mona Palmqvist, et al.. (2001). Protection against cold air and exercise-induced bronchoconstriction while on regular treatment with Oxis®. Respiratory Medicine. 95(6). 484–490. 28 indexed citations
17.
Andersson‐Engels, Stefan, Jaro Ankerst, Jonas Johansson, Katarina Svanberg, & Sune Svanberg. (1993). LASER‐INDUCED FLUORESCENCE IN MALIGNANT and NORMAL TISSUE OF RATS INJECTED WITH BENZOPORPHYRIN DERIVATIVE. Photochemistry and Photobiology. 57(s1). 978–983. 27 indexed citations
18.
Ankerst, Jaro & N.N. Jonsson. (1989). Adenovirous Type 9-Induced Tumorigenesis in the Rat Mammary Gland Related to Sex Hormonal State. JNCI Journal of the National Cancer Institute. 81(4). 294–298. 22 indexed citations
19.
Zoucas, E., R. Fäldt, & Jaro Ankerst. (1985). Effect of Latex-Stimulated Granulocytes on Platelet Aggregation in Man. Pathophysiology of Haemostasis and Thrombosis. 15(3). 176–181. 7 indexed citations
20.
Sjögren, H O, Jun Minowada, & Jaro Ankerst. (1967). SPECIFIC TRANSPLANTATION ANTIGENS OF MOUSE SARCOMAS INDUCED BY ADENOVIRUS TYPE 12. The Journal of Experimental Medicine. 125(4). 689–701. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacques Hébert Breakdown of academic impact, for papers by Harold H. Newball Breakdown of academic impact, for papers by Jeffrey J. Atkinson Breakdown of academic impact, for papers by J J Mascali Breakdown of academic impact, for papers by Raphael Breuer Breakdown of academic impact, for papers by Musa Khaitov Breakdown of academic impact, for papers by Jean LeRiche Breakdown of academic impact, for papers by John R. Shainoff Breakdown of academic impact, for papers by Annemarie van Schadewijk Breakdown of academic impact, for papers by Shaul Kochwa
Rankless by CCL
2026